AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
Basel Medical Group Ltd Ordinary Shares
XNAS · usd
SIC 8011 · SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
FIGI AK-E47E4855F8
4.44▼ 0.01 (-0.22%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
4.45
Day's Range
4.38 – 4.50
52-Week Range
0.38 – 10.60
Volume
1.6M
Avg Volume
1.5M
Share Statistics
Shares Outstanding
Employees
70
Exchange
XNAS
Listed
2025-02-25
Share count as of June 30, 2025

Basel Medical Group Ltd Ordinary Shares (BMGL) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Basel Medical Group Ltd Ordinary Shares (BMGL)
What is Basel Medical Group Ltd Ordinary Shares's Market Cap?
Basel Medical Group Ltd Ordinary Shares's Market Cap is $83.4M, based on as-reported figures from SEC (XBRL) filings.
What is Basel Medical Group Ltd Ordinary Shares's Enterprise Value?
Basel Medical Group Ltd Ordinary Shares's Enterprise Value is $85.1M, based on as-reported figures from SEC (XBRL) filings.
What is Basel Medical Group Ltd Ordinary Shares's Trailing P/E?
Basel Medical Group Ltd Ordinary Shares's Trailing P/E is 54.5×, based on as-reported figures from SEC (XBRL) filings.
What is Basel Medical Group Ltd Ordinary Shares's Price / Sales?
Basel Medical Group Ltd Ordinary Shares's Price / Sales is 11.2×, based on as-reported figures from SEC (XBRL) filings.
What is Basel Medical Group Ltd Ordinary Shares's EV / Revenue?
Basel Medical Group Ltd Ordinary Shares's EV / Revenue is 11.5×, based on as-reported figures from SEC (XBRL) filings.
What is Basel Medical Group Ltd Ordinary Shares's EV / EBITDA?
Basel Medical Group Ltd Ordinary Shares's EV / EBITDA is 3.8×, based on as-reported figures from SEC (XBRL) filings.
What is Basel Medical Group Ltd Ordinary Shares's Revenue (TTM)?
Basel Medical Group Ltd Ordinary Shares's Revenue (TTM) is $7.4M, based on as-reported figures from SEC (XBRL) filings.
What is Basel Medical Group Ltd Ordinary Shares's Net Income (TTM)?
Basel Medical Group Ltd Ordinary Shares's Net Income (TTM) is $1.5M, based on as-reported figures from SEC (XBRL) filings.
What is Basel Medical Group Ltd Ordinary Shares's EBITDA?
Basel Medical Group Ltd Ordinary Shares's EBITDA is $2.3M, based on as-reported figures from SEC (XBRL) filings.
What is Basel Medical Group Ltd Ordinary Shares's Diluted EPS (TTM)?
Basel Medical Group Ltd Ordinary Shares's Diluted EPS (TTM) is 0.08, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · BMGLAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of SGD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2025Jun 30, 2024
Profit or loss [abstract]
Revenue
Non-Operating Income (Expense)
Consumables, medical supplies and other related expenses
Employee benefit expenses
Depreciation expense
Rent expense
Operating Income
Impairment loss on goodwill
Finance cost
(Loss)/Profit before tax
Income tax expense
(Loss)/Profit after tax
(Loss)/Profit for the year, representing total comprehensive income for the year
(Loss)/Profit attributable to:
Net Income
Net Income Attributable to Noncontrolling Interest
(Loss)/Profit for the year